Home > Income Statement > NATCO PHARMA

NATCO PHARMA
Revenue

    Back to Income Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹3,999 Cr₹2,707 Cr₹1,945 Cr₹2,052 Cr₹1,915 Cr

What is the latest Revenue of NATCO PHARMA ?

The latest Revenue ratio of NATCO PHARMA is ₹3,999 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹3,999 Cr
Mar2023₹2,707 Cr
Mar2022₹1,945 Cr
Mar2021₹2,052 Cr
Mar2020₹1,915 Cr

How is Revenue of NATCO PHARMA Trending?

Years Revenue % Change
Mar2024 ₹3,999 Cr
47.72
Mar2023 ₹2,707 Cr
39.20
Mar2022 ₹1,945 Cr
-5.23
Mar2021 ₹2,052 Cr
7.16
Mar2020 ₹1,915 Cr -

Compare Revenue of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹14,710.4 Cr 1% 6.5% -15.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,971.0 Cr -4.6% 0.7% 10.8% Stock Analytics
DIVIS LABORATORIES ₹161,153.0 Cr -1.2% 12.6% 51.2% Stock Analytics
CIPLA ₹122,717.0 Cr 0.7% 6% 9.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,392.0 Cr -1.8% -0.4% 25.1% Stock Analytics
DR REDDYS LABORATORIES ₹100,702.0 Cr 4% 8.9% -1.3% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

1%

6.5%

-15.3%

SENSEX

0.6%

11%

10.4%


You may also like the below Video Courses